Clinical trial condition

MCRPC

Explore clinical trials studying MCRPC. Study availability and eligibility vary by location and protocol.

19 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

MCRPC trial results

Not Yet Recruiting

Study of TYK-00540 Combined With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）

NCT07104643

Conditions: MCRPC
Locations: Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Completed

Study of INKmune in Patients With mCRPC (CaRe Prostate)

NCT06056791

Conditions: Cancer, MCRPC, Metastatic Castration-resistant Prostate Cancer, +1 more
Locations: VA Greater Los Angeles Healthcare System Los Angeles, California, United States

University of California, Los Angeles Los Angeles, California, United States

Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States

Carl & Edyth Lindner Center for Research and Education at The Christ Hospital and The Christ Hospital Cancer Center Cincinnati, Ohio, United States

View Trial Details

Completed

Performance of 177Lu-PSMA-I&T for RLT in mCRPC - Prospective Multicenter Swiss Registry Study

NCT06830408

Conditions: MCRPC
Locations: University Hospital Basel Basel, Canton of Basel-City, Switzerland

CHUV Lausanne, Canton of Vaud, Switzerland

Kantonspital Aarau Aarau, Switzerland

Inselspital Bern, Switzerland

View Trial Details

Completed

Sipuleucel-T and Stereotactic Ablative Body Radiation (SABR) for Metastatic Castrate-resistant Prostate Cancer (mCRPC)

NCT01818986

Conditions: MCRPC, Metastatic Castrate-resistant Prostate Cancer
Locations: University of Texas Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Active, Not Recruiting

Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

NCT06866548

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +13 more
Locations: Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Active, Not Recruiting

Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC

NCT03395197

Conditions: MCRPC
Locations: Alaska Urological Institute dba Alaska Clinical Research Center Anchorage, Alaska, United States

Ironwood Physicians P.C. dba Ironwood Cancer & Research Centers Chandler, Arizona, United States

Ironwood Physicians P.C. dba Ironwood Cancer & Research Centers Gilbert, Arizona, United States

Ironwood Physicians P.C. dba Ironwood Cancer & Research Centers Mesa, Arizona, United States

View all 368 locations

View Trial Details

Active, Not Recruiting

Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer

NCT05340374

Conditions: MCRPC, Metastatic Castration-resistant Prostate Cancer
Locations: St Vincent's Hospital Sydney, New South Wales, Australia

Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

View Trial Details

Active, Not Recruiting

Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer

NCT05383079

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations: Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

View Trial Details

Active, Not Recruiting

A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard Therapy

NCT05547061

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations: Chonnam National University Hwasun Hospital Hwasun, South Korea

Seoul National University Hospital Seoul, South Korea

Asan Medical Center Seoul, South Korea

Seoul National University Bundang Hospital Seoul, South Korea

View Trial Details

MCRPC

MCRPC trial results

Related conditions